XML 49 R40.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Segment Reporting (Tables)
6 Months Ended
Jun. 30, 2024
Segment Reporting [Abstract]  
Schedule of Business Segment Information

The Company’s business segment information was as follows (in thousands):

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

Proteomics

 

$

28,209

 

 

$

18,088

 

 

$

64,389

 

 

$

33,288

 

Genomics

 

 

8,996

 

 

 

9,578

 

 

 

18,356

 

 

 

19,497

 

Total revenue

 

$

37,205

 

 

$

27,666

 

 

$

82,745

 

 

$

52,785

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from operations:

 

 

 

 

 

 

 

 

 

 

 

 

Proteomics

 

$

(23,739

)

 

$

(3,710

)

 

$

(38,275

)

 

$

(9,191

)

Genomics

 

 

952

 

 

 

(437

)

 

 

756

 

 

 

(260

)

Corporate expenses

 

 

(19,201

)

 

 

(11,035

)

 

 

(43,204

)

 

 

(21,174

)

Restructuring and related charges

 

 

(5,749

)

 

 

(2,267

)

 

 

(10,033

)

 

 

(3,417

)

Transaction and integration expenses

 

 

(2,782

)

 

 

 

 

 

(19,945

)

 

 

 

Total income (loss) from operations

 

$

(50,519

)

 

$

(17,449

)

 

$

(110,701

)

 

$

(34,042

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation & amortization:

 

 

 

 

 

 

 

 

 

 

 

 

Proteomics

 

 

1,896

 

 

 

3,240

 

 

$

5,253

 

 

$

6,512

 

Genomics

 

 

346

 

 

 

164

 

 

 

747

 

 

 

330

 

Corporate

 

 

1,614

 

 

 

222

 

 

 

3,050

 

 

 

446

 

Total depreciation & amortization

 

$

3,856

 

 

$

3,626

 

 

$

9,050

 

 

$

7,288